Myomo Strengthens Intellectual Property Portfolio with Receipt of Key Patent in Japan
Brings the total number of patents issued on the MyoPro® device globally to 20 BOSTON (February 17, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the granting of patent number 6998478 titled “Powered […]
Independent Research with Myomo’s MyoPro® Shows Clinically Significant Gains in Motor Function in Individuals with Chronic Moderate-to-Severe Arm Weakness
Adds to Body of Evidence Supporting the Utility of MyoPro in Stroke and Traumatic Brain Injury Patients BOSTON (February 14, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that new research measuring the […]
Myomo To Present at the Sidoti Winter Small Cap Conference
BOSTON, Mass. (January 13, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, and David Henry, Myomo’s chief financial officer, will present at the […]
Myomo Provides Update on MyoPro® Insurance Reimbursement
BOSTON, Mass (January 10, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update on reimbursement for its MyoPro device by a large private payer that was denying pre-authorized claims after delivery […]
Myomo Announces MyoPro 2+
Company Continues to Innovate with Digital Technologies BOSTON, Mass. (January 6, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the availability of MyoPro 2+, an enhanced version of its popular MyoPro powered […]
Myomo Amends China Joint Venture Agreement, Executes Technology and Trademark License Agreement
Receipt of Full License Fee and Technology Transfer Expected to Begin before March 31, 2022 BOSTON, Mass. (January 5, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces the entry into anamended and […]
Myomo Third Quarter 2021 Financial Results Feature Record Revenue
Revenue of $4.4 million up 128% over prior year, up 159% year-to-date Gross margin of 75% up 1,900 basis points over prior year Backlog increased to 177 units Conference call begins at 4:30 p.m. Eastern time today BOSTON, Mass. (November 10, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical […]
Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021
BOSTON, Mass., (November 3, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three and nine months ended September 30, 2021 on November 10, 2021 […]
Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants
BOSTON, Mass. (October 15, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced it has entered into agreements with certain of its holders of its existing 2020 investor warrants exercisable for 1,015,798 shares […]
Myomo, Inc. to Present at Fall Harvest – Best Ideas from the Buy-Side on October 5th
BOSTON, Mass. (September 28, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, and David Henry, Myomo’s chief financial officer, will present at the […]